Evidence map›Paper›PMID 26592175›Full record

ArticleScientific reports2015

Genome-wide association study-identified SNPs (rs3790844, rs3790843) in the NR5A2 gene and risk of pancreatic cancer in Japanese.

Makoto Ueno, Shinichi Ohkawa, Manabu Morimoto, Hiroshi Ishii, Masato Matsuyama, Sawako Kuruma, Naoto Egawa, Haruhisa Nakao, Mitsuru Mori, Keitaro Matsuo and 10 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Replication and Genetic Risk Score Analysis for Pancreatic Cancer in a Diverse Multiethnic Population.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2020
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 12 institutions in 1 country.

Makoto UenoHepatobiliary and Pancreatic Medical Oncology Division, Kanagawa Cancer Center Hospital, Kanagawa 241-8515, Japan.
Shinichi OhkawaHepatobiliary and Pancreatic Medical Oncology Division, Kanagawa Cancer Center Hospital, Kanagawa 241-8515, Japan.
Manabu MorimotoHepatobiliary and Pancreatic Medical Oncology Division, Kanagawa Cancer Center Hospital, Kanagawa 241-8515, Japan.
Hiroshi IshiiHepatobiliary and Pancreatic Section, Gastroenterological Division, Cancer Institute Hospital, Tokyo 135-8550, Japan.
Masato MatsuyamaHepatobiliary and Pancreatic Section, Gastroenterological Division, Cancer Institute Hospital, Tokyo 135-8550, Japan.
Sawako KurumaDepartment of Internal Medicine, Tokyo Metropolitan Komagome Hospital, Tokyo 113-8677, Japan.
Naoto EgawaTokyo Metropolitan Ohtsuka Hospital, Tokyo 170-8476, Japan.
Haruhisa NakaoDivision of Gastroenterology, Department of Internal Medicine, Aichi Medical University School of Medicine, Nagakute 480-1195, Japan.
Mitsuru MoriDepartment of Public Health, Sapporo Medical University School of Medicine, Sapporo 060-0061, Japan.
Keitaro MatsuoDivision of Molecular Medicine, Aichi Cancer Center Research Insitute, Nagoya 762-6111, Japan.
Satoyo HosonoDivision of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya 762-6111, Japan.
Masanori NojimaDepartment of Public Health, Sapporo Medical University School of Medicine, Sapporo 060-0061, Japan.
Kenji WakaiDepartment of Preventive Medicine, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan.
Kozue NakamuraDepartment of Food and Nutrition, Gifu City Women's College, Gifu 501-2592, Japan.
Akiko TamakoshiDepartment of Public Health, Hokkaido University Graduate School of Medicine, Sapporo 060-8638, Japan.
Mami TakahashiCentral Animal Division, National Cancer Center Research Institute, Tokyo 104-0045, Japan.
Kazuaki ShimadaDepartment of Hepatobiliary and Pancreatic Surgery, National Cancer Center Hospital, Tokyo 104-0045, Japan.
Takeshi NishiyamaDepartment of Public Health, Aichi Medical University School of Medicine, Nagakute 480-1195, Japan.
Shogo KikuchiDepartment of Public Health, Aichi Medical University School of Medicine, Nagakute 480-1195, Japan.
Yingsong LinDepartment of Public Health, Aichi Medical University School of Medicine, Nagakute 480-1195, Japan.
Aichi Medical University · JPAichi Cancer Center · JPKanagawa Cancer CenterSapporo Medical University · JPThe Cancer Institute Hospital · JPGifu City Women's College · JPHokkaido University · JPKanagawa Prefectural Hospital Organization · JPNagoya University · JPTokyo Metropolitan Komagome Hospital · JPTokyo Metropolitan Ohtsuka Hospital · JPTokyo National Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We genotyped 2 SNPs (rs3790844 T/C and rs3790843 G/A) in the NR5A2 gene that were identified in a genome-wide association study (GWAS) of pancreatic cancer in populations of mainly European ancestry, and we examined their associations with pancreatic cancer risk in a case-control study of 360 patients and 400 control subjects in Japan. Unconditional logistic regression models were used to estimate odds ratios (ORs) and 95% confidence intervals (CIs). The SNPs were in linkage disequilibrium (r(2) = 0.80). For rs3790843, the multivariable-adjusted OR was 0.75 (95% CI: 0.41-1.36) and 0.60 (95%CI: 0.33-1.08) for subjects with the AG and AA genotype, respectively, compared to subjects with the GG genotype. The per allele OR was 0.78 (0.62-0.99) (P = 0.046). For rs3790844, the multivariable-adjusted OR was 0.65 (95% CI: 0.37-1.14) and 0.47 (95%CI: 0.27-0.83) for subjects with the CT and CC genotype, respectively, compared to subjects with the TT genotype. The per allele OR was 0.70 (0.56-0.89) (P = 0.003). Our case-control study found that rs3790843 and rs3790844 in the NR5A2 gene are associated with pancreatic cancer risk in Japanese subjects. The direction of association is consistent with the prior findings from GWASs.

Indexed as

Genetic Predisposition to DiseasePolymorphism, Single NucleotideAdenocarcinomaAgedAllelesAsian PeopleCase-Control StudiesFemaleGene ExpressionGene FrequencyGenome-Wide Association StudyHumansLinkage DisequilibriumLogistic ModelsMaleMiddle AgedNR5A2 protein, humanReceptors, Cytoplasmic and Nuclear

Identifiers

PMID26592175
PMCPMC4655467
OpenAlexW2183332479

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.